Erythema nodosum is a common skin condition characterized by painful, reddish-purple lumps that appear on the shins and lower legs. The lumps can range in size from a few millimeters to several centimeters and may be accompanied by fever, joint pain, and swollen lymph nodes. Although the condition is usually self-limiting and resolves without treatment, it can be quite uncomfortable and cause significant disruption to an individual’s life. In this comprehensive guide, we will explore the causes, diagnosis, and treatment of erythema nodosum.
Erythema nodosum is an inflammatory disorder of the subcutaneous fat that affects the lower legs and shins. It is characterized by tender, reddish-purple lumps that can range in size from a few millimeters to several centimeters. The condition is usually self-limiting and resolves without treatment, but it can be quite uncomfortable and cause significant disruption to an individual’s life.
The exact cause of erythema nodosum is unknown, but it is thought to be an immune system reaction to certain triggers. Common triggers include certain medications, infections, and inflammatory diseases. Other possible causes include pregnancy, sarcoidosis, inflammatory bowel disease, and Behcet’s disease.
The diagnosis of erythema nodosum is usually based on the physical examination of the affected area. The condition is usually easily recognizable due to the presence of tender, reddish-purple lumps. In some cases, a biopsy may be performed to confirm the diagnosis. Blood tests may also be performed to look for signs of infection or other underlying conditions.
The treatment for erythema nodosum depends on the underlying cause. In cases where the condition is caused by an infection or an underlying medical condition, the underlying cause must be treated in order to resolve the erythema nodosum. In cases where the cause is unknown or the condition is self-limiting, treatment is usually focused on relieving the symptoms. Common treatments include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and antibiotics.
The best way to prevent erythema nodosum is to avoid known triggers, such as certain medications, infections, and inflammatory diseases. It is also important to practice good hygiene and to get regular check-ups to identify any underlying medical conditions.
Erythema nodosum is a common skin condition characterized by painful, reddish-purple lumps that appear on the shins and lower legs. The exact cause of the condition is unknown, but it is thought to be an immune system reaction to certain triggers. The diagnosis is usually based on the physical examination of the affected area and treatment is usually focused on relieving the symptoms. In some cases, treatment of the underlying cause may be necessary. The best way to prevent erythema nodosum is to avoid known triggers and to practice good hygiene.
1.
Glioblastoma treatment breakthrough shows promise
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Study suggests exercise could reduce breast cancer recurrence
4.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
5.
Daily physical activity, even at light intensities, linked to lower cancer risk
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
3.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
4.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation